Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Feldmann, M, Brennan, F, Paleolog, E, Taylor, P, Maini, R
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	1997

Míreanna comhchosúla

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
de réir: Maini, R, et al.
Foilsithe / Cruthaithe: (1998)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1997)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
de réir: Paleolog, E, et al.
Foilsithe / Cruthaithe: (1996)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1994)

Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.
de réir: Feldman, M, et al.
Foilsithe / Cruthaithe: (1998)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
de réir: Feldmann, M
Foilsithe / Cruthaithe: (1996)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
de réir: Ulfgren, A, et al.
Foilsithe / Cruthaithe: (2000)

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
de réir: Paleolog, E, et al.
Foilsithe / Cruthaithe: (1998)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
de réir: Maini, R, et al.
Foilsithe / Cruthaithe: (1999)

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
de réir: Deleuran, B, et al.
Foilsithe / Cruthaithe: (1992)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
de réir: Brennan, F, et al.
Foilsithe / Cruthaithe: (1995)

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
de réir: Taylor, P, et al.
Foilsithe / Cruthaithe: (2000)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
de réir: Maini, R, et al.
Foilsithe / Cruthaithe: (1995)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1995)

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
de réir: Haworth, C, et al.
Foilsithe / Cruthaithe: (1991)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
de réir: Elliot, M, et al.
Foilsithe / Cruthaithe: (2008)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
de réir: Elliott, M, et al.
Foilsithe / Cruthaithe: (1993)

A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis.
de réir: Marinova-Mutafchieva, L, et al.
Foilsithe / Cruthaithe: (2000)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
de réir: Maini, R, et al.
Foilsithe / Cruthaithe: (2000)

Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply
de réir: Taylor, P, et al.
Foilsithe / Cruthaithe: (2001)

Therapeutic actions of cyclosporine and anti-tumor necrosis factor alpha in collagen-induced arthritis and the effect of combination therapy.
de réir: Williams, R, et al.
Foilsithe / Cruthaithe: (1998)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
de réir: Maini, R, et al.
Foilsithe / Cruthaithe: (1994)

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
de réir: Chu, C, et al.
Foilsithe / Cruthaithe: (1991)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
de réir: Maini, R, et al.
Foilsithe / Cruthaithe: (1993)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (2001)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
de réir: Elliott, M, et al.
Foilsithe / Cruthaithe: (1995)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (2011)

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
de réir: Brennan, F, et al.
Foilsithe / Cruthaithe: (1997)

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
de réir: Lipsky, P, et al.
Foilsithe / Cruthaithe: (2000)

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
de réir: Maini, R, et al.
Foilsithe / Cruthaithe: (1995)

Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (2004)

TNF alpha--a pivotal role in rheumatoid arthritis?
de réir: Brennan, F, et al.
Foilsithe / Cruthaithe: (1992)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
de réir: Maini, R, et al.
Foilsithe / Cruthaithe: (1994)

INCREASED EXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTORS ON CELLS ISOLATED FROM RHEUMATOID-ARTHRITIS SYNOVIAL JOINTS
de réir: Gibbons, D, et al.
Foilsithe / Cruthaithe: (1992)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (2001)

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.
de réir: Tak, P, et al.
Foilsithe / Cruthaithe: (1996)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
de réir: Elliott, M, et al.
Foilsithe / Cruthaithe: (1994)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
de réir: Taylor, P, et al.
Foilsithe / Cruthaithe: (2000)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
de réir: Davis, D, et al.
Foilsithe / Cruthaithe: (1997)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
de réir: Feldmann, M, et al.
Foilsithe / Cruthaithe: (1995)